These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21625655)

  • 1. The young at risk of CVD are the least likely to receive preventive cardiovascular medications in New Zealand.
    Hobbs FD
    J Prim Health Care; 2011 Jun; 3(2):92. PubMed ID: 21625655
    [No Abstract]   [Full Text] [Related]  

  • 2. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
    Mehta S; Wells S; Riddell T; Kerr A; Pylypchuk R; Marshall R; Ameratunga S; Chan WC; Thornley S; Crengle S; Harrison J; Drury P; Elley CR; Bell F; Jackson R
    J Prim Health Care; 2011 Jun; 3(2):93-101. PubMed ID: 21625656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
    N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments.
    Simpson FO
    J Hypertens; 1997 Jan; 15(1):1-2. PubMed ID: 9050964
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations of the second Indo-U.S. health summit on prevention and control of cardiovascular disease among Asian Indians.
    Enas EA; Singh V; Munjal YP; Gupta R; Patel KC; Bhandari S; Agarwal AK; Joshi SR; Anoop M; Prabhakaran D; Shah B; Reddy S; Sharma B; Trehan N; Yavagal ST; Kasliwal RR;
    Indian Heart J; 2009; 61(3):265-74. PubMed ID: 20503833
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP; Holmes DP
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):587-8. PubMed ID: 22811502
    [No Abstract]   [Full Text] [Related]  

  • 9. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk assessment: audit findings from a nurse clinic--a quality improvement initiative.
    Waldron S; Horsburgh M
    J Prim Health Care; 2009 Sep; 1(3):226-31. PubMed ID: 20690387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular preventive activities in primary care].
    Villar Alvarez F; Maiques Galán A; Brotons Cuixart C; Torcal Laguna J; Ortega Sánchez-Pinilla R; Vilaseca Canals J; Forés García D; Banegas Banegas JR; Lobos Bejarano JM; Orozco Beltrán D; Gil Guillén VF; Llor Vila C; Lorenzo Piqueres A; Navarro Pérez J
    Aten Primaria; 2003 Dec; 32 Suppl 2():15-29. PubMed ID: 15116471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
    Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive cardiovascular recommendations].
    Maiques Galán A; Villar Alvarez F; Brotons Cuixart C; Torcal Laguna J; Orozco-Beltrán D; Navarro Pérez J; Lobos-Bejarano JM; Banegas Banegas JR; Ortega Sánchez-Pinilla R; Gil Guillén V; Solana Saura P;
    Aten Primaria; 2007 Nov; 39 Suppl 3():15-26. PubMed ID: 19288694
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice.
    Webb DR; Gray LJ; Khunti K; Campbell S; Dallosso H; Davies MJ
    Diabetes Res Clin Pract; 2011 Mar; 91(3):280-5. PubMed ID: 21194777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.
    Morrell J; Zeymer U; Baumgartner I; Limbourg T; Röther J; Bhatt DL; Steg PG;
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):270-7. PubMed ID: 20606595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.